20893 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Kallidins; Bradykinins; Related peptides
PHARMACEUTICAL COMPOSITION COMPRISING TRYPTOPHAN AND PHYLLOKININ DERIVATIVE FOR USE IN TREATING PSYCHIATRIC AND PSYCHOLOGICAL CONDITIONS
#2Application of Inhibitors Targeting CD226 Molecules in Anti-Tumor Metastasis
#3PROLYL HYDROXYLASE DOMAIN INHIBITOR TREATMENT TO IMPROVE SURVIVABILITY OF HEMORRHAGIC SHOCK
#4COMPOSITIONS FOR THE DELIVERY OF PROTEINS
#5Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions
#6PAIN RESPONSE MEDIATOR COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
#7Adhesion prevention material
#8METHODS AND COMPOSITIONS FOR THE MODULATION OF BETA-ENDORPHIN LEVELS
#9Kinin-based theranostic probes for solid cancers and uses thereof
#10SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#11Solvent/polymer solutions as suspension vehicles
#12Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disorders
#13Methods and Pharmaceutical Compositions for Prevention or Treatment of Ischemia Related Organ Damage
#14Nutritional supplement for disinhibiting therapy of psychiatric patients
#15Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
#16Solvent/polymer solutions as suspension vehicles
#17Solvent/polymer solutions as suspension vehicles
#18Solvent/polymer solutions as suspension vehicles
#19GABA release-regulating agent in cerebellum
#20DUAL ANTAGONISM OF ENDOTHELIN TYPE A AND BRADYKININ B1 RECEPTORS FOR TREATING PAIN AND PREVENTING CARTILAGE DEGRADATION
#21Solvent/polymer solutions as suspension vehicles
#22Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
#23Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#24Use of a octreotide as a therapeutic agent
#25SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#26USE OF OCTREOTIDE AS A THERAPEUTIC AGENT
#27USE OF BPP-B AS A THERAPEUTIC AGENT
#28MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
#29Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
#30Transthyretin variants
#31Antagonists of the bradykinin B1 receptor
#32Antagonists of the bradykinin B1 receptor
#33Methods and compositions for preventing and/or treating pancreatitis
#34USE OF 5-PHOSPHODIESTERASE INHIBITORS TO ENHANCE THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER OF ABNORMAL BRAIN TISSUE AND THE BLOOD-TUMOR BARRIER
#35Antagonists of the bradykinin B1 receptor
#36Use of Antagonists of the Bradykinin B2 Receptor for the Treatment of Osteoarthrosis
#37Alzheimer's disease-specific alterations of the ERK1/ERK2 Phosphorylation ratio-Alzheimer's disease-specific molecular biomarkers (ADSMB)
#38Vessel enlargement by arteriogenic factor delivery
#39Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
#40Cardiovascular compositions and methods using combinations of anti-platelet agents
#41Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation
#42Bradykinin receptor antagonists and uses thereof
#43Method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists
#44INDUCTION OF APOPTOSIS OF MALIGNANT CELLS BY ACTIVATION OF CALCIUM-ACTIVATED POTASSIUM CHANNELS
#45Method of conjugating aminothiol containing molecules to vehicles
#46Solvent/polymer solutions as suspension vehicles
#47Process for the production of implants
#48Lactone bearing absorbable polymers
#49Antagonists of the brandykinin B1 receptor
#50Histidine-rich glycoprotein